Cellular levels of free arachidonic acid (AA) are controlled by a deacylation/reacylation cycle whereby the fatty acid is liberated by phospholipases and reincorporated by acyltransferases. We have found that the esterification of AA into membrane phospholipids is a Ca2+-independent process and that it is blocked up to 60-70%o by a bromoenollactone (BEL) that is a selective inhibitor ofa newly discovered Ca2+-independent phospholipase A2 (PLA2) in macrophages.
The observed inhibition correlates with a decreased steadystate level of lysophospholipids as well as with the inhibition of the Ca2+-independent PLA2 activity in these cells. This inhibition is specific for the Ca2 -independent PLA2 in that neither group IV PLA2, group II PLA2, arachidonoyl-CoA synthetase, lysophospholipid:arachidonoyl-CoA acyltransferase, nor CoA-independent transacylase is affected by treatment with BEL. Moreover, two BEL analogs that are not inhibitors of the Ca2+-independent PIA2-namely a bromomethyl ketone and methyl-BEL-do not inhibit AA incorporation into phospholipids. Esterification of palmitic acid is only slightly affected by BEL, indicating that de novo synthetic pathways are not inhibited by BEL. Collectively, the data suggest that the Ca2+-independent PLA2 in P388D1 macrophages plays a major role in regulating the incorporation of AA into membrane phospholipids by providing the lysophospholipid acceptor employed in the acylation reaction.
A general feature of membrane phospholipids is the positionspecific esterification of the glycerol phosphate backbone with fatty acids. Saturated fatty acids are usually found in the sn-1 position whereas polyunsaturated fatty acids such as arachidonic acid (AA) are usually found in the sn-2 position. AA is the common precursor of the eicosanoids, a family of biologically active compounds which include the prostaglandins and leukotrienes (for review, see ref. 1) . Because cellular AA is almost exclusively found in esterified form, the availability of this fatty acid is critical for eicosanoid biosynthesis (for review, see refs. [1] [2] [3] . In unstimulated cells, the cellular levels of free AA are primarily controlled by the highly active AA esterification system (3) (4) (5) . Thus, free AA provided to the cell or liberated by phospholipase A2 (PLA2) is rapidly converted to arachidonoyl-CoA by arachidonoyl-CoA synthetase at the expense of ATP and immediately incorporated into phospholipids by CoA-dependent acyltransferases (6, 7) .
The process of AA incorporation into phospholipids displays unique features when compared with that of other fatty acids. First, the enzymatic machinery responsible for AA esterification in various cell types appears to be highly selective for this fatty acid (3, 4) . Second, the major route for incorporation of AA into phospholipids is not mediated by the de novo pathway via acylation of glycerol phosphate and/or dihydroxy-FA FIG. 1. De novo and remodeling pathways for incorporation of free fatty acid (FA) into phospholipids. In the de novo pathway, FA is incorporated via fatty acyl-CoA into glycerol phosphate (GP) or dihydroxyacetone phosphate (DHAP) and into the resulting lysophosphatidic acid (lysoPA) by fatty acyl-CoA acyltransferases to form phosphatidic acid (PA). In macrophages, the PA can be converted to phosphatidylinositol (PI) or can be converted to diacylglycerol (DG), which is the precursor for phosphatidylcholine (PC) and phosphatidylethanolamine (PE), which in turn form phosphatidylserine (PS). In contrast, in the remodeling pathway, preformed PI, PS, PC, or PE is acted on by the Ca2+-independent PIA2 (iPLA2) to produce lysoPI, lysoPS, lysoPC or lysoPE; these can be reacylated by acyltransferases using fatty acyl-CoA. acetone phosphate to produce phosphatidic acid (PA), but rather by a deacylation/reacylation cycle (8) . It is believed that this cycle is largely responsible for remodeling of cellular phospholipids leading to the selective distribution of AA at the sn-2 position (Fig. 1) . Accordingly, the fatty acid at the sn-2 position of preexisting phospholipids is cleaved by PLA2, creating a lysophospholipid which is rapidly reesterified with another fatty acid by a CoA-dependent acyltransferase (2-7). Due to the exceedingly high activity of cellular arachidonoylCoA synthetase as compared with that of cellular PLA2, fatty acid activation appears not to limit AA incorporation into phospholipids (9) (10) (11) . Thus, in resting cells, availability of the lysophospholipid acceptor provided by a PLA2-like activity is a limiting factor for incorporation of AA into phospholipids.
Abbreviations: AA, arachidonic acid; BEL, bromoenollactone [(E)-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one]; BMK, bromomethyl ketone [6-bromo-2-(1-naphthyl)-5-oxohexanoic acid]; MeBEL, methyl-BEL [(E)-6-(1-bromoethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one]; PLA2, phospholipase A2; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; PA, phosphatidic acid. *To whom reprint requests should be addressed.
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Silica gel G-60 TLC plates were from Analtech. Organic solvents (analytical grade) were from Baker or Fisher. The Ca2+-independent PIA2 inhibitor (E)-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one (bromoenollactone, BEL) and its analogs 6-bromo-2-(1-naphthyl)-5-oxohexanoic acid (bromomethyl ketone, BMK) and (E)-6-(1-bromoethylene)tetrahy-
were synthesized in our laboratory as described (13) .
Cell Culture. P388D, cells were maintained at 37°C in a humidified atmosphere of 90% air and 10% CO2 in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (100 units/ml) streptomycin (100 ,ug/ml), and nonessential amino acids. Adherent cells were selected by passage of only adherent cells. The cells used in the experiments reported below were between passages 15 and 30. Cells were plated at 106 per well in six-well plates, allowed to adhere overnight, and used for experiments the following day. All experiments were conducted in serum-free Iscove's modified Dulbecco's medium. (10 nM; 0.5 ,uCi/ml). At the indicated times, supernatants were removed and the cell monolayers were gently washed with medium containing albumin at 5 mg/ml (14) . The cell monolayers were scraped twice with 0.05% Triton X-100, and total lipids were extracted according to Bligh and Dyer (15) . Lipids were separated by TLC with n-hexane/diethyl ether/acetic acid (70:30:1 by volume). In this system, phospholipids remain at the origin of the plate. For separation of phospholipid classes, plates that had been sprayed with 1% potassium oxalate were run twice, using the upper phase of a system consisting of ethyl acetate/isooctane/acetic acid/water (130:20:30:100 by volume) (16) . This system allowed a good resolution among major phospholipid classes. Radioactive content in the different lipid classes was quantitated by liquid scintillation counting. For preparation of Ca2+-depleted cells, cells were incubated with 1 mM EGTA and 40 ,uM quin-2 AM in a Ca2 -free medium for 60 min at 37°C (17) X-100/100 ,uM 1-palmitoyl-2-[14C]palmitoyl-sn-glycero-3-phosphocholine, in a final volume of 500 ,ul. The substrate was used in the form of mixed micelles of Triton X-100/ phospholipid at a molar ratio 4:1, obtained by a combination of heating (above 40°C), vortex mixing, and water bath sonication until the solution clarified (12) . At the end of the reaction, the radiolabeled fatty acid product was extracted by the modified Dole assay procedure (12) . Measurement of LysoPC Levels. For the measurement of lysoPC, cells were incubated with [3H]choline at 1 ,uCi/ml for 3 days. After the cells were treated with the indicated BEL doses for 30 min, cellular lipids were extracted with ice-cold 1-butanol as described (18) , and separated by TLC, with chloroform/methanol/acetic acid/water (50:40:6:0.6 by volume) as a solvent system. Spots corresponding to lysoPC were scraped and assayed for radioactivity by liquid scintillation counting.
Other Methods. Group IV PLA2 and group II PLA2 activities were assayed exactly as described (19) . Arachidonoyl-CoA synthetase was measured as described by Wilson et al. (20) . In brief, the assay mixture was composed of 20 mM MgCl2, 10 mM ATP, 1 mM coenzyme A, 1 mM 2-mercaptoethanol, 130
,uM [3H]AA, 100 mM Tris HCl (pH 8.0), and cell homogenate (up to 100 jig of protein) in a total volume of 0.15 ml. After incubation at 37°C for 10 min, the reaction was terminated by the addition of 2.25 ml of 2-propanol/heptane/2 M sulfuric acid (40:10:1 by volume). Heptane (1.5 ml) and water (1 ml) were added and the mixture was vortexed vigorously before centrifugation at 1000 x g for 5 min. The aqueous phase was extracted twice with 2 ml of heptane containing nonradioactive AA at 4 mg/ml, and a 1-ml aliquot of the aqueous phase was used for radioactivity determination by liquid scintillation counting.
Arachidonoyl-CoA:lysophospholipid acyltransferase activity was measured as described by Lands et al. (21) . The assay mixture was composed of 50 ,uM arachidonoyl-CoA, 50 ,uM of 1-[1-14C]palmitoyl-2-lyso-sn-glycero-3-phosphocholine, 50 mM Tris HCl (pH 7.5), and cell homogenate (up to 100 jig of protein) in a final volume of 0.15 ml. After incubation at 37°C for 10 min, the reaction was stopped by the addition of 0.56 ml of chloroform/methanol (1:2 by volume). Chloroform (0.19 ml) and water (0.19 ml) were added and the mixture was vortexed vigorously before centrifugation at 1000 x g for 5 min.
The organic phase was evaporated and chromatographed on Silica gel G plates with chloroform/methanol/acetic acid/ water (50:25:8:4 by volume) as the developing solvent. PC and lysoPC were scraped off the plate and assayed for radioactivity by liquid scintillation counting.
CoA-independent transacylase activity was measured as described by Venable et al. (22) . The assay mixture was composed of 120 mM NaCl, 2 mM EGTA, 5 ,uM 1-0-
[3H]hexadecyl-2-lyso-sn-glycero-3-phosphocholine (lyso platelet-activating factor, lysoPAF), 100 mM Tris-HCl (pH 7.5), and cell homogenate (up to 100 ,ug of protein) in a final volume of 0.2 ml. In this assay system, the lysophospholipid acceptor for the acylation reaction (lysoPAF) is added to the assay mixture and the phospholipid donor is provided by the homogenate. After incubation at 37°C for 5 min, the reaction was stopped by the addition of 0.75 ml of chloroform/methanol (1:2). Chloroform (0.25 ml) and water (0.25 ml) were added and the mixture was vortexed vigorously before centrifugation at 1000 x g for 5 min. The organic phase was evaporated and chro- (24) . Not surprisingly, receptor activation of AA release via either or both of these enzymes is strongly dependent on Ca2+ availability (25) .
However, the release of AA is not the only cellular event being regulated by P[A2 enzymes. Other aspects of phospholipid metabolism-particularly fatty acid incorporation into and remodeling among phospholipids-have long been thought to depend on a PLA2 whose identity has remained unknown (3) (4) (5) (6) (7) (8) . The process of AA incorporation into phospholipids dominates over AA release in unstimulated cells; hence the overwhelming amount of cellular AA is found in esterified form, not as a free fatty acid.
We have previously shown that P388D1 cells avidly take up free [3H]AA from the incubation medium and incorporate it very quickly into their membrane phospholipids (25) . In these cells, PLA2-mediated release of AA from stimulated cells is dependent on the presence of extracellular Ca2+ (25) . In contrast, in unstimulated cells, AA incorporation into cell phospholipids does not require extracellular Ca2+ (Fig. 2) cellular Ca2+ depletion, suggesting that the PLA2 responsible for supplying the lysophospholipid acceptor for AA esterification is Ca2+-independent. Role of Ca2+-Independent PLA2. We recently purified a Ca2+-independent PLA2 from the cytosol of P388D1 cells (12) . This enzyme does not show preference for phospholipids containing AA; in fact, it prefers palmitoyl over arachidonoyl residues (12) . The Ca2+-independent PLA2 from P388D1 macrophages is potently and irreversibly inhibited by the mechanism-based inhibitor BEL (13) . This compound manifests > 1000-fold selectivity for inhibition of Ca2I-independent PLA2 enzymes versus the Ca2+-dependent PLA2 enzymes (27) . BEL inhibits the purified Ca2+-independent PLA2 from P388D1 cells in a concentration-dependent manner, with halfmaximal inhibition occurring at 60 nM after a 5-min preincubation at 40°C (13) .
Measurements of Ca2+-independent PLA2 activity in homogenates prepared from cells treated with variable amounts of BEL for 30 min demonstrate a dose-dependent inhibition of enzyme activity, complete inhibition being reached at BEL concentrations higher than 25 ,uM (Fig. 3A) . Cells treated with (Fig. 3B) Bradford (23) .
Inhibition by BEL of AA esterification into phospholipids directly correlated with the inhibition of endogenous Ca2+-independent PLA2 activity (Fig. 3C) . In agreement with these data, BEL decreased the steady-state level of lysoPC in a dose-dependent and saturable manner (Fig. 4) . Importantly, pretreatment with BEL at doses higher than 25 ,uM did not result in further inhibition of lysoPC levels, demonstrating saturation of inhibition through BEL-sensitive pathways at the 65% level. This is the same saturating level observed for inhibition of [3H]AA esterification (compare Fig. 3B and Fig. 4) .
In addition to the Ca2+-independent PLA2, P388D1 macrophages contain two other PLA2 activities-namely, group IV and group II (19) . Measurements 30 min. Group IV PLA2 activity was assayed by using mixed vesicles of PC/diacylglycerol at a molar ratio 2:1, in the presence of 2-mercaptoethanol (19) . Group II PIA2 activity was measured by the Escherichia coli assay (19) . Arachidonoyl-CoA synthetase, lysophospholipid:arachidonoylCoA acyltransferase, and CoA-independent transacylase were determined as described in the text. ND, not determined.
Proc. Natl. Acad. Sci. USA 92 (1995) (22), respectively. No effect of BEL on these enzyme activities was detected at any concentration tested (Table 1) .
Collectively, the results of this study demonstrate that AA esterification into P388D1 macrophages is a Ca2+-independent process and lead to the identification of a Ca2+-independent PLA2 as an enzyme responsible for regulating this process under resting conditions. Due to the extraordinary importance of acylation reactions in keeping the intracellular amounts of free AA at very low levels (3) (4) (5) (6) (7) (8) , the Ca2 -independent PLA2 appears to be a key enzyme in regulating the basal levels of eicosanoids synthesized by P388D1 cells.
